MAPK6 — Mitogen-Activated Protein Kinase 6

MAPK6 — Mitogen-Activated Protein Kinase 6

Introduction

MAPK6 (Mitogen-Activated Protein Kinase 6), also known as ERK3 (Extracellular Signal-Regulated Kinase 3), is an atypical member of the MAP kinase family. Unlike classical MAP kinases such as ERK1/2, MAPK6 has distinct regulatory mechanisms and cellular functions. It plays critical roles in cell division, differentiation, stress responses, and synaptic plasticity. In the nervous system, MAPK6 is involved in neurodevelopment, learning and memory, and has been increasingly recognized for its contributions to neurodegenerative processes. This page provides comprehensive coverage of MAPK6's molecular function, disease associations, expression patterns, and its emerging role in Alzheimer's disease ([AD](/diseases/alzheimers-disease)), [Parkinson's disease](/diseases/parkinsons-disease), and related neurodegenerative disorders.

Overview

MAPK6 — Mitogen-Activated Protein Kinase 6

Introduction

MAPK6 (Mitogen-Activated Protein Kinase 6), also known as ERK3 (Extracellular Signal-Regulated Kinase 3), is an atypical member of the MAP kinase family. Unlike classical MAP kinases such as ERK1/2, MAPK6 has distinct regulatory mechanisms and cellular functions. It plays critical roles in cell division, differentiation, stress responses, and synaptic plasticity. In the nervous system, MAPK6 is involved in neurodevelopment, learning and memory, and has been increasingly recognized for its contributions to neurodegenerative processes. This page provides comprehensive coverage of MAPK6's molecular function, disease associations, expression patterns, and its emerging role in Alzheimer's disease ([AD](/diseases/alzheimers-disease)), [Parkinson's disease](/diseases/parkinsons-disease), and related neurodegenerative disorders.

Overview

MAPK6 is a serine/threonine protein kinase that functions as part of the MAP kinase signaling cascade. While it shares structural homology with other MAP kinases, MAPK6 exhibits unique features including its lack of classical activation loop phosphorylation sites and its regulation through nuclear-cytoplasmic shuttling. Research over the past two decades has revealed that MAPK6 is involved in diverse cellular processes beyond its initially characterized roles in cell cycle progression, including neuronal differentiation, synaptic plasticity, and stress response pathways. The kinase has emerged as a potential therapeutic target in neurodegeneration due to its regulation of key processes including tau phosphorylation, neuroinflammation, and neuronal survival.

<div class="infobox infobox-gene">
<div class="infobox-header">MAPK6 — Mitogen-Activated Protein Kinase 6</div>

Overview

MAPK6 (ERK3) is an atypical MAP kinase involved in cell division, differentiation, stress responses, and synaptic plasticity. It plays critical roles in neurodevelopment and has been increasingly recognized for its contributions to neurodegenerative processes.

<table class="infobox-table">
<tr><th>Gene Symbol</th><td>MAPK6</td></tr>
<tr><th>Full Name</th><td>Mitogen-Activated Protein Kinase 6</td></tr>
<tr><th>Alternative Names</th><td>ERK3, PRKM6</td></tr>
<tr><th>Chromosomal Location</th><td>15q21.2</td></tr>
<tr><th>NCBI Gene ID</th><td>[5603](https://www.ncbi.nlm.nih.gov/gene/5603)</td></tr>
<tr><th>OMIM</th><td>[616431](https://www.omim.org/entry/616431)</td></tr>
<tr><th>Ensembl ID</th><td>[ENSG00000170048](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170048)</td></tr>
<tr><th>UniProt</th><td>[Q9Y4G2](https://www.uniprot.org/uniprot/Q9Y4G2)</td></tr>
<tr><th>Protein Length</th><td>721 amino acids</td></tr>
<tr><th>Protein Kinase Domain</th><td>Serine/Threonine protein kinase, MAPK family</td></tr>
<tr><th>Associated Diseases</th><td>Alzheimer's disease, Parkinson's disease, neurodevelopmental disorders, cancer</td></tr>
</table>
</div>

Summary

MAPK6 encodes mitogen-activated protein kinase 6, an atypical member of the MAP kinase family. Unlike classical MAP kinases, MAPK6 is regulated primarily through interactions with MAPKAP kinases (MK2/MK3) rather than through dual phosphorylation of the activation loop. MAPK6 participates in diverse signaling pathways controlling cell proliferation, differentiation, stress responses, and synaptic plasticity. In the brain, MAPK6 is expressed in neurons and glial cells where it modulates neuronal development, cognitive function, and responses to neurotoxic stress. Dysregulation of MAPK6 signaling has been implicated in the pathogenesis of Alzheimer's disease, Parkinson's disease, and other neurodegenerative conditions, making it a subject of ongoing research interest.

Molecular Function

Catalytic Activity

MAPK6 is a serine/threonine protein kinase that catalyzes the transfer of phosphate groups from ATP to serine or threonine residues on substrate proteins. The canonical kinase domain of MAPK6 spans residues 46-330 and contains the characteristic motifs required for ATP binding and catalysis. Unlike classical MAP kinases such as ERK1/2, MAPK6 lacks the TXY activation motif in its activation loop; instead, it is constitutively active as a kinase and is regulated primarily through:

Interaction with MAPKAP Kinases

The primary downstream targets of MAPK6 are MAPKAP kinase 2 (MK2, also known as MAPKAPK2) and MAPKAP kinase 3 (MK3). The MAPK6-MK2/3 module regulates:

• Cytoskeletal dynamics: Through phosphorylation of proteins involved in actin remodeling
• Stress response: Activation of p38 MAPK pathway effectors
• Gene expression: Through transcription factor phosphorylation
• Cell cycle progression: Regulation of G1/S transition

Substrate Specificity

MAPK6 phosphorylates several known substrates:

• MAPKAPK2/MAPKAPK3: Primary physiological substrates
• MIST1: Basic leucine zipper transcription factor
• Gre2: Stress-responsive enzyme (in yeast)
• SEPT2: Cytoskeletal protein involved in cytokinesis

Signaling Pathways

MAPK Signaling Cascades

MAPK6 occupies a unique position in the MAP kinase signaling network. While it can be activated by certain extracellular stimuli, it is not typically integrated into the classic RAS-RAF-MEK-ERK1/2 cascade. Instead, MAPK6:

Cross-Talk with Neurodegeneration Pathways

In neurons, MAPK6 interfaces with several pathways implicated in neurodegeneration:

• Tau phosphorylation: MAPK6 can phosphorylate tau protein at specific sites, potentially contributing to NFT formation in [Alzheimer's disease](/diseases/alzheimers-disease)
• Alpha-synuclein: Evidence suggests MAPK6 may influence alpha-synuclein phosphorylation and aggregation relevant to [Parkinson's disease](/diseases/parkinsons-disease)
• Neuroinflammation: Regulates cytokine expression and glial activation
• Apoptosis: Modulates both pro-survival and pro-apoptotic signaling

Expression Pattern

MAPK6 exhibits a broad expression pattern across tissues, with particularly high levels in the brain:

Central Nervous System

• Neurons: High expression in pyramidal neurons of the [cortex](/brain-regions/cortex) and [hippocampus](/brain-regions/hippocampus)
• Astrocytes: Present in astrocytes throughout the brain
• Oligodendrocytes: Expression in myelinating oligodendrocytes
• Microglia: Detectable in microglial cells, particularly in activated states

Peripheral Tissues

Highest expression is observed in brain, with moderate levels in:

• Heart
• Lung
• Liver
• Skeletal muscle

Cellular Localization

MAPK6 is predominantly cytoplasmic but undergoes nuclear-cytoplasmic shuttling. In unstimulated cells, it is distributed throughout the cytoplasm. Upon certain stimuli or stress, MAPK6 can translocate to the nucleus where it may phosphorylate nuclear substrates.

Role in Neurodegeneration

Alzheimer's Disease

Multiple lines of evidence link MAPK6 to Alzheimer's disease pathogenesis:

Parkinson's Disease

In Parkinson's disease context:

Other Neurodegenerative Conditions

• Huntington's disease: Altered MAPK6 signaling has been reported in HD models
• Amyotrophic lateral sclerosis (ALS): May contribute to motor neuron degeneration
• Frontotemporal dementia: Links to tau pathology and neuronal stress responses

Interaction Network

| Interaction Partner | Relationship | Functional Significance |
|---------------------|--------------|------------------------|
| MAPKAPK2 (MK2) | Substrate/activator | Primary downstream kinase in signaling module |
| MAPKAPK3 (MK3) | Substrate/activator | Secondary downstream kinase |
| HSP90AA1 | Co-chaperone | Required for MAPK6 stability and function |
| 14-3-3 proteins | Binding partner | Regulates subcellular localization |
| Cyclin-dependent kinases | Cross-talk | Cell cycle regulation |
| p38 MAPK | Parallel pathway | Stress response signaling |
| AKT1 | Cross-talk | Survival signaling modulation |

Research Findings

Key Studies

Emerging Research Directions

• Biomarker potential: MAPK6 and its phosphorylated forms are being investigated as potential biomarkers for neurodegenerative disease diagnosis and progression
• Therapeutic modulation: Strategies to modulate MAPK6 activity for neuroprotective effects
• Understanding isoform-specific functions: The existence of MAPK6 splice variants and their distinct functions

Animal Models

Mouse Models

• Mapk6 knockout mice: Viable but show subtle developmental abnormalities and altered stress responses
• Conditional knockout: Brain-specific deletion reveals roles in learning and memory
• Transgenic overexpression: Models with neuronal MAPK6 overexpression show altered synaptic plasticity

Zebrafish Models

Zebrafish have been used to study MAPK6 function in neural development, revealing requirements for proper brain morphogenesis and neuronal differentiation.

Clinical Relevance

Genetic Associations

While MAPK6 is not a high-penetrance disease gene for monogenic neurodegeneration, polymorphisms in the MAPK6 gene have been associated with:

• Modified risk for sporadic Alzheimer's disease
• Age of onset variations in Parkinson's disease
• Response to certain therapeutic interventions

Therapeutic Implications

MAPK6 represents a potential therapeutic target for neurodegeneration:

See Also

• [MAPK signaling in neurodegeneration](/mechanisms/mapk-signaling-neurodegeneration) — related signaling pathways
• [Alzheimer's disease](/diseases/alzheimers-disease) — related disease
• [Parkinson's disease](/diseases/parkinsons-disease) — related disease
• [Tau protein](/proteins/tau-protein) — phosphorylated by MAPK6
• [Alpha-synuclein](/proteins/alpha-synuclein) — Lewy body component
• [Synaptic plasticity](/mechanisms/synaptic-plasticity) — MAPK6 in cognitive function
• [Neuroinflammation](/mechanisms/neuroinflammation) — inflammatory pathways

External Links

• [NCBI Gene: MAPK6](https://www.ncbi.nlm.nih.gov/gene/5603)
• [UniProt: Q9Y4G2](https://www.uniprot.org/uniprot/Q9Y4G2)
• [Ensembl: ENSG00000170048](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000170048)
• [OMIM: 616431](https://www.omim.org/entry/616431)
• [PDB: MAPK6 kinase domain structure](https://www.rcsb.org/structure/XXXX)
• [PubMed: MAPK6 publications](https://pubmed.ncbi.nlm.nih.gov/?term=MAPK6)

References